Trials / Terminated
TerminatedNCT01449175
A Registry Study of the AeriSeal® System or Lung Volume Reduction in Patients With Advanced Emphysema
- Status
- Terminated
- Phase
- —
- Study type
- Observational
- Enrollment
- 54 (estimated)
- Sponsor
- Aeris Therapeutics · Industry
- Sex
- All
- Age
- 40 Years
- Healthy volunteers
- Not accepted
Summary
The purpose of this study is to provide post market clinical follow-up (PMCF) to obtain long term safety and efficacy information about the AeriSeal System treatment in patients with advanced emphysema.
Detailed description
The purpose of this study is to provide post market clinical follow-up (PMCF) to obtain long term safety and efficacy information about the AeriSeal System treatment in patients with advanced homogeneous or heterogeneous emphysema.
Conditions
Timeline
- Start date
- 2011-01-01
- Primary completion
- 2013-11-01
- Completion
- 2013-11-01
- First posted
- 2011-10-10
- Last updated
- 2013-11-14
Locations
8 sites across 4 countries: Austria, France, Germany, Israel
Source: ClinicalTrials.gov record NCT01449175. Inclusion in this directory is not an endorsement.